Baird Medical says it knows of no undisclosed reason for share price decline
BDMD•Baird Medical said it knew of no material development or undisclosed reason explaining its recent ordinary share price decline. Management said it believes the current market valuation does not reflect the business’s strength or growth potential.
1. Company statement
Baird Medical said Nov. 4 it knew of no material development or undisclosed reason explaining the recent decline in its ordinary share price. Management said it believes the current market valuation does not reflect the strength of the underlying business or its growth potential, and the company is monitoring share-price fluctuations and trading activity.
